Keywords
gastric cancer
GASTRIC CANCER, GASTRIC CANCER
Adequate resection with lymphadenectomy remains the core of curative treatment for patients with advanced gastric cancer in the era of peri-operative chemotherapy. In total gastrectomy, the Japanese Gastric Cancer Association (JGCA) guidelines recommend radical resection with adequate lymphadenectomy, consisting of a modified D2 lymph node dissection with a minimum of 15 lymph nodes. Taking into consideration that D2 lymphadenectomy leads to superior outcomes in survival in comparison to D1 resection [The here presented study is a retrospective analysis on the data from the randomized clinical trial on open versus minimally invasive total gastrectomy (STOMACH trial) [The aim of the present retrospective analysis is to investigate the 3-year survival and to assess the differences in harvested lymph node stations between the two operation modalities, along with the distribution of positive nodes in patients with peri-operative chemotherapy.